NextGen Healthcare, Inc. (NXGN)

NextGen Healthcare Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Year Ending	TTM	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020	Mar 31, 2019
Net Income	-6.21	-2.65	1.62	9.52	7.5	24.49
Depreciation & Amortization	39.17	39.41	48.05	56	55.9	43.13
Share-Based Compensation	32.98	32.41	27.2	23.51	19.64	15.74
Other Operating Activities	-73.59	-25.5	-23.32	9.5	2.56	-32.89
Operating Cash Flow	-7.65	43.66	53.55	98.52	85.6	50.48
Operating Cash Flow Growth	-	-18.46%	-45.65%	15.09%	69.59%	-31.83%
Capital Expenditures	-35.7	-37.26	-28.08	-28.34	-26.88	-25.52
Acquisitions	-51.3	-40.05	0	-0.21	-71.69	0
Change in Investments	-145.2	-139.58	0	0	0	0
Other Investing Activities	-	-	-	-	2.5	-
Investing Cash Flow	-232.19	-216.89	-28.08	-28.55	-96.07	-25.52
Share Issuance / Repurchase	-34.31	-43.04	-30.86	3.48	2.41	7.53
Debt Issued / Paid	266.52	266.52	0	-130.42	118	-26
Other Financing Activities	-11.83	-10.85	-6.43	-4.77	-4.14	-3.18
Financing Cash Flow	220.38	212.62	-37.29	-131.72	116.27	-21.65
Exchange Rate Effect	-0.06	-0.15	0	0	0	0
Net Cash Flow	-19.53	39.24	-11.83	-61.74	105.8	3.3
Free Cash Flow	-43.35	6.4	25.46	70.18	58.72	24.95
Free Cash Flow Growth	-	-74.88%	-63.72%	19.51%	135.33%	-45.01%
Free Cash Flow Margin	-6.24%	0.98%	4.27%	12.60%	10.87%	4.72%
Free Cash Flow Per Share	-0.65	0.10	0.38	1.05	0.90	0.39

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).